Dr. Warner graduated in pharmacology in 1986 from King’s College London. He then moved to the newly established William Harvey Research Institute to pursue his PhD studies under the supervision of Prof. Sir John Vane (Nobel Laureate, 1982) during which time he was awarded the Premier Prix Annuel de Recherche en Phlébologie. In 1989 he completed his PhD and went to pursue his post-doctoral studies with Ferid Murad (Nobel Laureate 1998) at Northwestern University and Abbott Laboratories, Chicago. He returned to the William Harvey Research Institute in 1992, being awarded a British Heart Foundation lectureship in 1995. He was promoted Reader in Pharmacology in 1999 and awarded a personal chair in Vascular Inflammation in 2000, at which time he was the recipient of the British Pharmacology Society’s Novartis Prize. He has been listed by the Instit. for Scientific Information among the top 0.5% of cited pharmacologists. Currently he is Dept. Dean for Research in the School of Medicine and Dentistry and Deputy Director (Research & Innovation) of QMUL’s Life Science Initiative and previously SMD Deputy Dean for Postgraduate Research. He is a Fellow of the British Pharmacological Society, the American Heart Association and the Society of Biology, he is also a member of the British Society for Cardiovascular Research, International Society for Hypertension Research and the International Society on Thrombosis and Haemostasis. He is currently principal editor of the journal ‘Platelets’.
Joseph C. Wu, MD, PhD is Director of the Stanford Cardiovascular Institute and Simon H. Stertzer Professor of Medicine (Cardiology) and Radiology at the Stanford School of Medicine. Dr. Wu received his MD from Yale University School of Medicine. He trained in internal medicine and cardiology at UCLA followed by a PhD in the Dept of Molecular Pharmacology. His clinical interests involve cardiovascular imaging and adult congenital heart disease. His lab works on biological mechanisms of patient-specific and disease-specific induced pluripotent stem cells (iPSCs). The main goals are to (i) understand basic cardiovascular disease mechanisms, (ii) accelerate drug discovery and screening, (iii) develop “clinical trial in a dish” concept, and (iv) implement precision cardiovascular medicine for prevention and treatment of patients. His lab uses a combination of genomics, stem cells, cellular & molecular biology, physiological testing, and molecular imaging technologies to better understand molecular and pathophysiological processes.
Associate Professor at Rutgers-New Jersey Medical School, Editor of American Journal of Medical and Biological Research, Dataset Papers in Biology, Frontiers in Physiology, Journal of Cardiovascular Disease Research, PLOS One, World Journal Of Hypertension, and World Journal of Cardiology.
Researcher at Bloodworks Research Institute and UW Medicine, University of Washington. Current work mainly focuses on zwitterionic-based surface coatings for long-term biomedical applications.
Dr. Yang’s research focuses on a group of gasotransmitters, especially H2S, in the regulation of cellular functions and human diseases. Dr. Yang has received numerous awards and recognitions, including New Investigator award from the Heart and Stroke Foundation of Canada and Maureen Andrew Award from Heart and Stroke Foundation of Ontario. In his career, Dr. Yang has published ~100 peer-reviewed research articles, some of them published in high-impact journals, including as Science, Circulation, PNAS, and EMBO report etc. Their total citations are 5,951 (April 26, 2017).
Professor at the Second Hospital of Jilin University.
Research Keywords: Cancer research, Stem Cell, Biochemistry, Bioenergetics, Biology and life sciences, Biotechnology, Breast tumors, Cancer, Clinical research, Complementary and alternative medicine, Cytochemistry, Cytometry, Pharmacology, Neuropharmacology, Gastrointestinal tumors, Immunochemistry, Leukemias, Lung cancer.
On the Editorial Board of the Chinese Journal of Lung Cancer and the Chinese Journal of Clinical Oncology
Assistant Professor, Fellow of the American College of Sports Medicine (FACSM), and Director of Molecular Physiology and Rehabilitation Research Lab at The Ohio State University, College of Medicine.